A systemmatic literature review on indirect costs of women with breast cancer
Abstract Introduction The rising incidence of breast cancer places a financial burden on national health services and economies. The objective of this review is to present a detailed analysis of the research and literature on indirect costs of breast cancer. Methods English literature databases from...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | Cost Effectiveness and Resource Allocation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12962-022-00408-6 |
_version_ | 1797980154812694528 |
---|---|
author | Saeed Mohammadpour Samira Soleimanpour Javad Javan-Noughabi Nasrin Aboulhasanbeigi Gallehzan Ali Aboutorabi Reza Jahangiri Rafat Bagherzadeh Julia F. Gorman Ali Nemati |
author_facet | Saeed Mohammadpour Samira Soleimanpour Javad Javan-Noughabi Nasrin Aboulhasanbeigi Gallehzan Ali Aboutorabi Reza Jahangiri Rafat Bagherzadeh Julia F. Gorman Ali Nemati |
author_sort | Saeed Mohammadpour |
collection | DOAJ |
description | Abstract Introduction The rising incidence of breast cancer places a financial burden on national health services and economies. The objective of this review is to present a detailed analysis of the research and literature on indirect costs of breast cancer. Methods English literature databases from 2000 to 2020 were searched to find studies related to the objective of the present review. Study selection and data extraction was undertaken independently by two authors. Also, quality assessment was done using a checklist designed by Stunhldreher et al. Results The current study chose 33 studies that were eligible from a total of 2825 records obtained. The cost of lost productivity due to premature death based on human capital approach ranged from $22,386 to $52 billion. The cost burden from productivity lost due to premature death based on friction cost approach ranged from $1488.61 to $4,518,628.5. The cost burden from productivity lost due to morbidity with the human capital approach was reported as $126,857,360.69 to $596,659,071.28. The cost of lost productivity arising from informal caregivers with the human capital approach was $297,548.46 to $308 billion. Conclusion Evaluation of the existing evidence revealed the indirect costs of breast cancer in women to be significantly high. This study did a thorough review on the indirect costs associated with breast cancer in women which could serve as a guide to help pick the appropriate method for calculating the indirect costs of breast cancer based on existing methods, approach and data. There is a need for calculations to be standardised since the heterogeneity of results in different domains from various studies makes it impossible for comparisons to be made among different countries. |
first_indexed | 2024-04-11T05:51:09Z |
format | Article |
id | doaj.art-712151bfcadb49dea58e3f18fe417ab8 |
institution | Directory Open Access Journal |
issn | 1478-7547 |
language | English |
last_indexed | 2024-04-11T05:51:09Z |
publishDate | 2022-12-01 |
publisher | BMC |
record_format | Article |
series | Cost Effectiveness and Resource Allocation |
spelling | doaj.art-712151bfcadb49dea58e3f18fe417ab82022-12-22T04:42:05ZengBMCCost Effectiveness and Resource Allocation1478-75472022-12-0120111910.1186/s12962-022-00408-6A systemmatic literature review on indirect costs of women with breast cancerSaeed Mohammadpour0Samira Soleimanpour1Javad Javan-Noughabi2Nasrin Aboulhasanbeigi Gallehzan3Ali Aboutorabi4Reza Jahangiri5Rafat Bagherzadeh6Julia F. Gorman7Ali Nemati8Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical SciencesDepartment of Medical Library and Information Science, School of Health Management and Information Sciences, Iran University of Medical SciencesSocial Determinants of Health Research Center, Mashhad University of Medical SciencesDepartment of Health Economics, School of Health Management and Information Sciences, Iran University of Medical SciencesDepartment of Health Economics, School of Health Management and Information Sciences, Iran University of Medical SciencesDepartment of Health Economics, Health Management and Economics Research Center, Iran University of Medical SciencesEnglish Language Department, School of Health Management and Information Sciences, Iran University of Medical SciencesGraduate School of Humanities and Social Sciences, University of MelbourneDepartment of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical SciencesAbstract Introduction The rising incidence of breast cancer places a financial burden on national health services and economies. The objective of this review is to present a detailed analysis of the research and literature on indirect costs of breast cancer. Methods English literature databases from 2000 to 2020 were searched to find studies related to the objective of the present review. Study selection and data extraction was undertaken independently by two authors. Also, quality assessment was done using a checklist designed by Stunhldreher et al. Results The current study chose 33 studies that were eligible from a total of 2825 records obtained. The cost of lost productivity due to premature death based on human capital approach ranged from $22,386 to $52 billion. The cost burden from productivity lost due to premature death based on friction cost approach ranged from $1488.61 to $4,518,628.5. The cost burden from productivity lost due to morbidity with the human capital approach was reported as $126,857,360.69 to $596,659,071.28. The cost of lost productivity arising from informal caregivers with the human capital approach was $297,548.46 to $308 billion. Conclusion Evaluation of the existing evidence revealed the indirect costs of breast cancer in women to be significantly high. This study did a thorough review on the indirect costs associated with breast cancer in women which could serve as a guide to help pick the appropriate method for calculating the indirect costs of breast cancer based on existing methods, approach and data. There is a need for calculations to be standardised since the heterogeneity of results in different domains from various studies makes it impossible for comparisons to be made among different countries.https://doi.org/10.1186/s12962-022-00408-6Breast neoplasmsBreast cancerIndirect costFemaleSystematic review |
spellingShingle | Saeed Mohammadpour Samira Soleimanpour Javad Javan-Noughabi Nasrin Aboulhasanbeigi Gallehzan Ali Aboutorabi Reza Jahangiri Rafat Bagherzadeh Julia F. Gorman Ali Nemati A systemmatic literature review on indirect costs of women with breast cancer Cost Effectiveness and Resource Allocation Breast neoplasms Breast cancer Indirect cost Female Systematic review |
title | A systemmatic literature review on indirect costs of women with breast cancer |
title_full | A systemmatic literature review on indirect costs of women with breast cancer |
title_fullStr | A systemmatic literature review on indirect costs of women with breast cancer |
title_full_unstemmed | A systemmatic literature review on indirect costs of women with breast cancer |
title_short | A systemmatic literature review on indirect costs of women with breast cancer |
title_sort | systemmatic literature review on indirect costs of women with breast cancer |
topic | Breast neoplasms Breast cancer Indirect cost Female Systematic review |
url | https://doi.org/10.1186/s12962-022-00408-6 |
work_keys_str_mv | AT saeedmohammadpour asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT samirasoleimanpour asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT javadjavannoughabi asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT nasrinaboulhasanbeigigallehzan asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT aliaboutorabi asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT rezajahangiri asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT rafatbagherzadeh asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT juliafgorman asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT alinemati asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT saeedmohammadpour systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT samirasoleimanpour systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT javadjavannoughabi systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT nasrinaboulhasanbeigigallehzan systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT aliaboutorabi systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT rezajahangiri systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT rafatbagherzadeh systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT juliafgorman systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer AT alinemati systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer |